Redwood Bio is pioneering an Alzheimer's test that can detect the disease in its early stages using a simple blood sample. Redwood’s paradigm-shifting technology is capable of detecting Alzheimer's up to 15 years before symptoms appear, with a sensitivity that is 100-fold higher than the most advanced diagnostic instruments currently available. Redwood's Alzheimer's test has the potential to become the standard of care due to its ease of use, cost effectiveness, and ability to significantly improve patient outcomes. Beyond Alzheimer's disease testing, Redwood's technology could revolutionize the medical diagnostics industry by replacing the gold standard ELISA tests with its 100,000-fold higher sensitivity, faster assay times, and lower cost. Redwood Bio is based in California and is headed by scientists and engineers with decades of experience in research and development from MIT and UC Santa Cruz.
Company Details
- Employees
- 4
- Founded
- -
- Address
- 17777 Main Street, Suite E-2, Irvine,california 92614,united States
- Industry
- Medical And Diagnostic Laboratories
- NAICS
-
Medical and Diagnostic LaboratoriesMedical LaboratoriesDiagnostic Imaging Centers
- Keywords
- alzehemier and elisa.
- HQ
- IRVINE, California
Redwood Bio Questions
Redwood Bio's LinkedIn profile is https://www.linkedin.com/company/redwood-bio
Redwood Bio has
4 employees.
View email and phone details for 4
employees at Redwood Bio.
Redwood Bio's industry is
Medical and Diagnostic Laboratories
Redwood Bio's top competitors are
Air Sciences Inc.,
Funex,
Sorrento Networks,
Recode Therapeutics,
Rheosense Inc.,
Ocean Science & Technology,
Resistancebio,
York Space Systems Llc,
Thintronics®,
Acrigen Biosciences.
Redwood Bio's categories are Medical and Diagnostic Laboratories
Redwood Bio's founding year is 2022
